Share-based Compensation (Tables)

9 Months Ended

Mar. 31, 2021

Share-based Compensation

Schedule of weighted average assumptions

	Nine Months Ended
	March 31, 2021			March 31, 2020
Risk-free interest rate		0.2	%		1.9	%
Expected volatility		82.5	%		73.7	%
Expected dividend yield		—	%		—	%
Forfeiture rate		—	%		—	%
Expected term		5.0	years		5.1	years
Weighted average fair value	$	3.86		$	4.04

Summary of stock option award activity

						Weighted
		Weighted-				Average
		Average		Aggregate		Remaining
		Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards	Price		Value		Life (yrs.)
Outstanding at June 30, 2020	991	$	12.11	$	678	5.6
Granted	309	$	5.95
Exercised	(37)	$	4.12	$	61
Forfeited, expired or repurchased	(217)	$	17.17
Outstanding at March 31, 2021	1,046	$	9.51	$	62	7.4
Vested and expected to vest at March 31, 2021	1,045	$	9.51	$	62	7.4
Exercisable at March 31, 2021	383	$	14.82	$	62	5.1

Summary of non-vested restricted stock awards

		Weighted
		Average Grant -		Aggregate
(In thousands, except for weighted average price data)	Awards	date Fair Value		Intrinsic Value
Non-vested at June 30, 2020	1,344	$	8.70
Granted	894		5.74
Vested	(792)		8.49	$	4,613
Forfeited	(75)		9.57
Non-vested at March 31, 2021	1,371	$	6.85

Schedule of non-vested performance-based shares

		Weighted
		Average Grant -
(In thousands, except for weighted average price and life data)	Awards	date Fair Value
Non-vested at June 30, 2020	204	$	12.99
Granted	339	$	9.22
Performance adjustment (1)	(12)	$	25.58
Non-vested at March 31, 2021	531	$	10.29

(1) Represents the adjustment based on the performance of the September 2017 awards, which was below the Threshold goal level at the end of the three-year performance period.

Schedule of allocation of share-based compensation

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
(In thousands)	2021		2020		2021		2020
Selling, general and administrative expenses	$	1,411	$	1,124	$	5,632	$	5,965
Research and development expenses		132		180		419		618
Cost of sales		320		566		1,145		1,753
Total	$	1,863	$	1,870	$	7,196	$	8,336
Tax benefit at statutory rate	$	419	$	421	$	1,619	$	1,876